Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden

被引：0
作者：
Johan Jendle
Jayne Smith-Palmer
Alexis Delbaere
Simona de Portu
Natalie Papo
William Valentine
Stéphane Roze
机构：
[1] Örebro University,
[2] Ossian Health Economics and Communications,undefined
[3] Medtronic International Trading Sarl,undefined
[4] HEVA HEOR,undefined
来源：
Diabetes Therapy | 2017年 / 8卷
关键词：
Cost; Cost-effectiveness; Type 1 diabetes; Sensor-augmented pump therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1015 / 1030
页数：15
相关论文
共 50 条
[1]   Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden [J].
Jendle, Johan ;
Smith-Palmer, Jayne ;
Delbaere, Alexis ;
de Portu, Simona ;
Papo, Natalie ;
Valentine, William ;
Roze, Stephane .
DIABETES THERAPY, 2017, 8 (05) :1015-1030
[2]   A Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension versus Standard Pump Therapy for Hypoglycemic Unaware Patients with Type 1 Diabetes [J].
Ly, Trang T. ;
Brnabic, Alan J. M. ;
Eggleston, Andrew ;
Kolivos, Athena ;
McBride, Margaret E. ;
Schrover, Rudolf ;
Jones, Timothy W. .
VALUE IN HEALTH, 2014, 17 (05) :561-569
[3]   Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark [J].
Roze, S. ;
de Portu, S. ;
Smith-Palmer, J. ;
Delbaere, A. ;
Valentine, W. ;
Ridderstrale, M. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 128 :6-14
[4]   Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey [J].
Roze, Stephane ;
Smith-Palmer, Jayne ;
de Portu, Simona ;
Saltik, A. Zeynep Ozdemir ;
Akgul, Tugba ;
Deyneli, Oguzhan .
DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (12) :727-735
[5]   Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type I diabetes in the Netherlands [J].
Roze, Stephane ;
Smith-Palmer, Jayne ;
de Portu, Simona ;
Delbaere, Alexis ;
de Brouwer, Bonnie ;
de Valk, Harold W. .
CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 :73-82
[6]   Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy [J].
Nicolucci, A. ;
Rossi, M. C. ;
D'Ostilio, D. ;
Delbaere, A. ;
de Portu, S. ;
Roze, S. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2018, 28 (07) :707-715
[7]   New-generation diabetes management: glucose sensor-augmented insulin pump therapy [J].
Cengiz, Eda ;
Sherr, Jennifer L. ;
Weinzimer, Stuart A. ;
Tamborlane, William V. .
EXPERT REVIEW OF MEDICAL DEVICES, 2011, 8 (04) :449-458
[8]   Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a UK perspective [J].
Roze, Stephane ;
Smith-Palmer, Jayne ;
Valentine, William J. ;
Cook, Mark ;
Jethwa, Manisha ;
de Portu, Simona ;
Pickup, John C. .
JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (03) :236-242
[9]   An Exploratory Cost-Effectiveness Analysis of Immune Therapy in Delaying the Initiation of Automated Insulin Delivery Systems in Type 1 Diabetes [J].
Mital, Shweta ;
Haller, Michael J. ;
Schatz, Desmond A. ;
Nguyen, Hai V. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2025,
[10]   Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Insulin-naive Chinese Patients With Type 2 Diabetes [J].
Cheng, Huafeng ;
Wan, Xu ;
Ma, Jing ;
Wu, Bin .
CLINICAL THERAPEUTICS, 2019, 41 (03) :445-455
12345